JONG MOON

Allopathic & Osteopathic Physicians|General Practice SHAFTER, CA NPI 1760545925

General Payments — all program years on this page

$669.12

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 39
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $217.22 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $217.2212

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $88.264
Acerta Pharma LLC $63.294
Lilly USA, LLC $32.682
Boehringer Ingelheim Pharmaceuticals, Inc. $19.901
GlaxoSmithKline, LLC. $13.091

By program year

Program yearAmountRecords
2019 $18.181
2020 $96.765
2021 $65.434
2022 $82.305
2023 $189.2312
2024 $217.2212

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096643889 Novo Nordisk Inc $19.61 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097255678 Novo Nordisk Inc $17.90 05/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097666165 Novo Nordisk Inc $24.23 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097789719 Novo Nordisk Inc $26.52 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104513258 AstraZeneca Pharmaceuticals LP $13.47 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105539147 AstraZeneca Pharmaceuticals LP $13.67 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105698158 AstraZeneca Pharmaceuticals LP $17.33 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105706610 AstraZeneca Pharmaceuticals LP $18.82 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116593224 GlaxoSmithKline, LLC. $13.09 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118143496 Boehringer Ingelheim Pharmaceuticals, Inc. $19.90 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135078949 Lilly USA, LLC $17.46 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135088419 Lilly USA, LLC $15.22 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.